CSTK
Invesco Comstock Contrarian Equity ETF
Invesco Comstock Contrarian Equity ETF seeks to achieve long-term capital appreciation by investing primarily in a diversified portfolio of equity securities that appear undervalued relative to their fundamentals.
Global
EQUITY
Active
MANAGEMENT STYLE
$ 122.6 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | May 05, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| BANK OF AMERICA CORP | 4.0 % |
| ALPHABET INC. CLASS A | 3.3 % |
| WELLS FARGO & CO | 3.3 % |
| CHEVRON CORP | 3.3 % |
| CVS CAREMARK CORP | 3.1 % |
| MICROSOFT CORP | 3.1 % |
| CISCO SYSTEMS INC | 3.0 % |
| MERCK & CO. INC. | 2.8 % |
| STATE STREET CORP | 2.7 % |
| JOHNSON CONTROLS INTERNATIONAL PLC | 2.6 % |
Constituent Breakdown
| Number of holdings | 52 |
| Herfindahl-Hirschman Index | 221 |
| Wgt avg mkt cap (mns) | $407,026 |
| Large cap (>$10bn) | 100.0% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 100.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 91.7 % |
 |
IRELAND | 5.7 % |
 |
NETHERLANDS | 2.6 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 8.4% | -- | -- | -- | -- | -- | -- | 26.4% |
| Dividend Yield | 0.6% | -- | -- | -- | -- | -- | -- | 2.6% |
| Total Returns | 9.0% | -- | -- | -- | -- | -- | -- | 29.0% | Ann. Volatility | 13.2% | -- | -- | -- | -- | -- | -- | 11.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 48 |
| ADV traded (mns) | $2 |
| Turnover | 1.2% |
| Avg. Bid/Ask (% of price) | 0.15% |
Technical Indicators
| 30d moving avg. (EMA) | $30.94 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 0.44/0.44 |
| Bollinger Bands (Upper/Lower) | $32.09/$30.37 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. CSTK |
Expenses vs. CSTK |
ALTAR Score™ vs. CSTK |
|---|---|---|---|---|
| LVDS | JPMorgan Fundamental Data Science Large Value ETF | 47.3% | +14 bp | -0.8% |
| DVND | Touchstone Dividend Select ETF | 32.7% | +32 bp | -0.7% |
| QUVU | Hartford Quality Value ETF | 28.8% | +11 bp | -0.3% |
| FUNL | CornerCap Fundametrics Large-Cap ETF | 28.0% | +15 bp | +0.4% |
| IWX | iShares Russell Top 200 Value ETF | 27.6% | -15 bp | -0.9% |
| SNPV | Xtrackers S&P 500 Value ESG ETF | 27.5% | -20 bp | -0.5% |
| BBLU | EA Bridgeway Blue Chip ETF EA Bridgeway Blue Chip ETF | 27.3% | -20 bp | -1.7% |
| SPVU | Invesco S&P 500 Enhanced Value ETF | 26.8% | -22 bp | +2.7% |
| DLN | WisdomTree U.S. LargeCap Dividend Fund | 26.7% | -7 bp | -0.4% |
| EQWL | Invesco S&P 100 Equal Weight ETF | 26.4% | -10 bp | -0.5% |
Risk and Returns: CSTK vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/20/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.4%
ALTAR SCORE™
79th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 713 funds in the Global Equity category with an average
ALTAR Score™ of 4.4% and a standard deviation
of 2.6%. CSTK's ALTAR Score™ is approximately 0.8 standard
deviations above the category average. This places CSTK in the 79th percentile
among funds in the category.
Sell-Side Consensus
$36.89
PRICE TARGET
+16.4%
UPSIDE